PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Trading 07-15 11:50:09 EDT

18.98

-0.33

-1.71%

High19.34	Low17.96	Vol943.32K
Open19.10	D1 Closing19.31	Amplitude7.12%
Mkt Cap1.08B	Tradable Cap1.02B	Total Shares56.91M
T/O17.72M	T/O Rate1.75%	Tradable Shares53.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":18.98,"timestamp":1784130602809,"preClose":19.31,"halted":0,"volume":943323,"delay":0,"changeRate":-0.01708959088555144,"floatShares":53951395,"shares":56909414,"eps":-1.832336,"marketStatus":"Trading","change":-0.33,"latestTime":"07-15 11:50:09 EDT","open":19.1,"high":19.335,"low":17.96,"amount":17718800.031678,"amplitude":0.071207,"askPrice":19,"askSize":357,"bidPrice":18.96,"bidSize":73,"shortable":0,"etf":0,"ttmEps":-1.832336,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1784145600000},"marketStatusCode":2,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":19.31,"preHourTrading":{"tag":"盘前","latestPrice":19.12,"preClose":19.31,"latestTime":"09:28 EDT","volume":2107,"amount":40608.988483,"timestamp":1784122081089,"change":-0.19,"changeRate":-0.009839,"amplitude":0.020958},"postHourTrading":{"tag":"盘后","latestPrice":19.31,"preClose":19.31,"latestTime":"19:59 EDT","volume":134529,"amount":2596853.8815,"timestamp":1784073582574,"change":0,"changeRate":0,"amplitude":0.016054},"volumeRatio":1.678983,"impliedVol":0.8985,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/PRCT/wiki","defaultTab":"wiki","newsList":[{"id":"2651872489","title":"Procept Biorobotics to Report Q2 Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651872489","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651872489?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:06","pubTimestamp":1784059606,"startTime":"0","endTime":"0","summary":"Procept BioRobotics to report Q2 results after market close, host conference callProcept BioRobotics to report Q2 2026 financial results on Aug. 4, 2026.Management conference call set for Aug. 4, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL59bfS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BN0W2V16.EUR","BCDF","SG9999014013.SGD","IE00BGHQF748.EUR","LU2324357040.USD","BK4112","LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014021.USD","BK4585","LU2210150020.SGD","NDAQ","IE00BKPKM429.USD","IE00B64PRP62.GBP","PRCT","LU2095319765.USD","BK4588","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4082","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651489656","title":"PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651489656","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651489656?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:05","pubTimestamp":1784059500,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., July  14, 2026  (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation(the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transfo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/14/3327244/0/en/PROCEPT-BioRobotics-to-Report-Second-Quarter-2026-Financial-Results-on-August-4th-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649603445","title":"Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649603445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649603445?lang=en_us&edition=fundamental","pubTime":"2026-07-07 10:45","pubTimestamp":1783392312,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Richard Newitter maintained a Hold rating on PROCEPT BioRobotics yesterday and set a price target of $25.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-procept-biorobotics-prct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-hold-rating-for-procept-biorobotics-prct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649626215","title":"Procept Biorobotics Cut to Hold from Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2649626215","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649626215?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:37","pubTimestamp":1783337820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings(END) Dow Jones NewswiresJuly 06, 2026 07:37 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649003625","title":"Procept Biorobotics Corp : Truist Securities Cuts to Hold from Buy; Cuts Target Price to $25 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2649003625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649003625?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:08","pubTimestamp":1783336084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","LU2324357040.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649288716","title":"Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2649288716","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649288716?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:49","pubTimestamp":1783331369,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $29.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648409664","title":"Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648409664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648409664?lang=en_us&edition=fundamental","pubTime":"2026-07-03 22:50","pubTimestamp":1783090219,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PROCEPT BioRobotics (PRCT) and Guardant Health (GH) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","XBI","BK4535","BK4551","LU0128526141.USD","BK4137","LU0109394709.USD","HELX","HCSG","PRCT","LU0029874061.USD","BK4581","GDOC","LABU","LU0320765992.SGD","LU0889565916.HKD","LFSC","GH","BK4082","EKG","GNOM","BK4196","BK4585","XLV","PTH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648265146","title":"U.S. Research Roundup- Crowdstrike, Factset, Rivian","url":"https://stock-news.laohu8.com/highlight/detail?id=2648265146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648265146?lang=en_us&edition=fundamental","pubTime":"2026-07-03 15:51","pubTimestamp":1783065104,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Crowdstrike, Factset, RivianJuly 3 -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Crowdstrike, Factset and Rivian, on Friday.HIGHLIGHTS* CrowdstrikeCRWD.O: Canaccord Genuity raises target price to $185 from $168.75* FactsetFDS.N: Jefferies raises target price to $253 from $225* RivianRIVN.O: JP Morgan raises target price to $15 from $9Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.* Constellation BrandsSTZ.N: HSBC raises target price to $192 from $190* CrowdstrikeCRWD.O: Canaccord Genuity raises target price to $185 from $168.75* FactsetFDS.N: Jefferies raises target price to $253 from $225* General Mills IncGIS.N: HSBC cuts target price to $41 from $44* Procept Biorobotics CorpPRCT.O: Truist Securities cuts to hold from buy* Procept Biorobotics CorpPRCT.O: Truist Securities cuts target price to $25 from $30* R","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL8N4350D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","BK4596","STZ","BK4528","LU1989763427.SGD","LU1804176565.USD","BK4532","LU2552382132.HKD","BK4212","PRCT","BK4547","LU1951198990.SGD","LU2023250504.SGD","BK4112","BK4169","IE00BZ9MQY76.HKD","BK4555","LU2552382058.USD","BK4566","CRWL","IE00B19Z9Z06.USD","FDS","CRWD","LU1720051108.HKD","LU1988902786.USD","BK4585","BK4097","BK4567","RIVN","LU0266013472.USD","BK4551","LU2265009873.SGD","LU1923622614.USD","LU1974910355.USD","LU1989763690.USD","LU2210150020.SGD","LU2433249047.HKD","GIS","BK4559","LU2264538146.SGD","LU1992135399.USD","BK4099","LU2106854487.HKD","BK4543","LU2552382215.SGD","LU1548497426.USD","RVNL","LU1951200564.SGD","LU1720051017.SGD","LU2286300806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648658626","title":"Procept Biorobotics Corp : Truist Securities Cuts to Hold from Buy; Cuts Target Price to $25 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2648658626","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648658626?lang=en_us&edition=fundamental","pubTime":"2026-07-03 11:56","pubTimestamp":1783050987,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN4340T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","BK4082","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648263840","title":"Procept BioRobotics downgraded to Hold from Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2648263840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648263840?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:10","pubTimestamp":1783023024,"startTime":"0","endTime":"0","summary":"Truist downgraded Procept BioRobotics (PRCT) to Hold from Buy with a price target of $25, down from $30, citing lowered confidence in the company’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-downgraded-to-hold-from-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-downgraded-to-hold-from-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647330613","title":"Procept Biorobotics Posts Investor Presentation Outlining Aquablation Growth Strategy in BPH Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2647330613","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647330613?lang=en_us&edition=fundamental","pubTime":"2026-06-30 01:16","pubTimestamp":1782753397,"startTime":"0","endTime":"0","summary":"Procept BioRobotics posts investor presentation outlining Aquablation growth strategy in BPH marketProcept outlined a strategy to shift Aquablation from an established option to a leading surgical tre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLcgFJHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645940897","title":"Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2645940897","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645940897?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:26","pubTimestamp":1782300409,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $31.40, according to analysts polled by FactSet.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645894054","title":"Procept Biorobotics Initiated at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2645894054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645894054?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:40","pubTimestamp":1782297600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 06:40 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645345894","title":"Procept BioRobotics initiated with an Outperform at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2645345894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645345894?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:10","pubTimestamp":1782295859,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Vijay Kumar initiated coverage of Procept BioRobotics (PRCT) with an Outperform rating and $30 price target Over next 12 mon, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645919208","title":"Procept Biorobotics Corp : Evercore Isi Initiates Coverage with Outperform Rating; Price Target $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2645919208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645919208?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:02","pubTimestamp":1782295350,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W02D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645800708","title":"Analysts’ Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645800708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645800708?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:30","pubTimestamp":1782210611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-procept-biorobotics-prct-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-procept-biorobotics-prct-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU2324357040.USD","BK4139","PRME","LABU","PRCT","XLV","LU0029874061.USD","HCSG","LU0128526141.USD","XBI","BK4588","BK4585","BK4082","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645885042","title":"PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645885042","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645885042?lang=en_us&edition=fundamental","pubTime":"2026-06-23 14:32","pubTimestamp":1782196336,"startTime":"0","endTime":"0","summary":"Recent coverage shows PROCEPT BioRobotics, a surgical robotics company focused on urology, reporting strong year-over-year revenue and net profit growth alongside rising institutional ownership, even as technical indicators point to more sell than buy signals.\nAn interesting angle is that institutional shareholding has risen to more than total shares outstanding, suggesting heavy involvement from major asset managers despite the company’s still-low operating efficiency.\nWe’ll now examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-down-65-after-institutional-owne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-down-65-after-institutional-owne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","LU2324357040.USD","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644909804","title":"PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds","url":"https://stock-news.laohu8.com/highlight/detail?id=2644909804","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644909804?lang=en_us&edition=fundamental","pubTime":"2026-06-20 22:24","pubTimestamp":1781965441,"startTime":"0","endTime":"0","summary":"A fresh batch of commentary on PROCEPT BioRobotics (PRCT) is drawing attention to the stock after a recent summary highlighted rapid revenue scaling, expanding gross margins, and slightly lower management guidance.\nSee our latest analysis for PROCEPT BioRobotics.\nDespite the fresh commentary around high revenue growth and expanding margins, PROCEPT BioRobotics’ share price return tells a different story. The stock is down 24.9% over 30 days and the 1 year total shareholder return has declined...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-stock-could-be-14-undervalued-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-stock-could-be-14-undervalued-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","CEO","PRCT","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642236708","title":"PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2642236708","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642236708?lang=en_us&edition=fundamental","pubTime":"2026-06-12 02:19","pubTimestamp":1781201972,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics  shares were down 5.8% in afternoon trading on Thursday after Leerink Partners downgraded the company's stock to market perform from outperform and adjusted the price target to $29 from $31.Trading volume stood at more than 1.8 million shares against a daily average of about 1.4 million.Price: 27.42, Change: -1.68, Percent Change: -5.76","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642823859","title":"PROCEPT BioRobotics Cut to Market Perform From Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2642823859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642823859?lang=en_us&edition=fundamental","pubTime":"2026-06-11 22:43","pubTimestamp":1781188980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 10:43 ET (14:43 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":-0.0818},{"period":"1month","weight":-0.2488},{"period":"3month","weight":-0.2478},{"period":"6month","weight":-0.3669},{"period":"1year","weight":-0.668},{"period":"ytd","weight":-0.3862}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0741},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.2033},{"period":"ytd","weight":0.1025}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.079362},{"month":2,"riseRate":0.4,"avgChangeRate":0.005067},{"month":3,"riseRate":0.6,"avgChangeRate":0.037831},{"month":4,"riseRate":0.6,"avgChangeRate":0.00923},{"month":5,"riseRate":1,"avgChangeRate":0.124767},{"month":6,"riseRate":0.2,"avgChangeRate":-0.067371},{"month":7,"riseRate":0.4,"avgChangeRate":-0.024052},{"month":8,"riseRate":0.5,"avgChangeRate":0.030761},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027813},{"month":10,"riseRate":0.6,"avgChangeRate":0.021826},{"month":11,"riseRate":0.4,"avgChangeRate":0.016944},{"month":12,"riseRate":0.2,"avgChangeRate":-0.059852}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction